Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 27 | Le Pendeven YvesCFO | Open-market sale | SELL | $11K 2,832 sh | Mar 16, 2026 |
| 27 | Walsh Mark T.Director, CEO & Director | Option exercise | M | $753K 93.8K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 27 | Gupta PriyaInterim CFO | Open-market sale | SELL | $46K 7,263 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 27 | Montgomery Pamela W.Chief Legal Officer-Healthcare | Option exercise | M | — 1,523 sh | Mar 16, 2026 traded Mar 10, 2026 |
| 25 | Pelish Henry E.Chief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $542K 5,505 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 24 | Crow David MEVP, Head of Axos Clearing | Option exercise | M | $62K 738 sh | Mar 16, 2026 traded Mar 15, 2026 |
| 24 | Josh GottheimerDJoint | Purchase | BUY | $1,001 – $15K | Mar 16, 2026 traded Feb 27, 2026 |
| 24 | William R. KeatingDSelf | ALPHABET INC NOTE CALL MAKE WHOLE 4.70000% 11/15/2035 Purchase | BUY | $1,001 – $15K | Mar 16, 2026 traded Feb 20, 2026 |
| 24 | William R. KeatingDSelf | CHUBB INA HLDGS INC NOTE CALL MAKE WHOLE 5.00000% 03/15/2034 Purchase | BUY | $1,001 – $15K | Mar 16, 2026 traded Feb 20, 2026 |
| 24 | William R. KeatingDSelf | UNITED STATES TREAS BILLS ZERO CPN 0.00000% 03/24/2026 Purchase | BUY | $1,001 – $15K | Mar 16, 2026 traded Feb 20, 2026 |
| 24 | Harris RyanEVP Head of Fintech Solutions | Open-market sale | SELL | $239K 4,500 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 23 | Daggs Nicole JEVP, Human Res & Corp Svcs | Open-market sale · 10b5-1 plan | SELL | $69K 745 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 21 | Moore Kathryn ASVP, HUMAN RESOURCES | Option exercise | M | — 297 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 21 | Walsh Mark T.Director, CEO & Director | Option exercise | M | — 33.5K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 21 | Brown Brandon Louis Sr.SVP, Chief Accounting Officer | Option exercise | M | — 2,557 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 21 | Simhambhatla RaviEVP, CDIO - see remarks | Grant or award | A | — 2,394 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 21 | Niewiara James ASVP, GENERAL COUNSEL | Option exercise | M | — 494 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 21 | Muzzey DaleChief Scientific Officer | Grant or award | A | — 173.2K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 21 | Deskins Angela J.EVP, Chief People Officer | Option exercise | M | — 2,526 sh | Mar 16, 2026 traded Mar 14, 2026 |
| 21 | Foust WarrenInterim Co-CEO and Pres. & COO | Option exercise | M | — 9,775 sh | Mar 16, 2026 traded Mar 14, 2026 |
| 21 | Deskins Angela J.EVP, Chief People Officer | Option exercise | M | — 2,526 sh | Mar 16, 2026 traded Mar 14, 2026 |
| 21 | Gilligan SarahChief Sup Chn & Transform Ofcr | Option exercise | M | — 3,439 sh | Mar 16, 2026 traded Mar 14, 2026 |
| 21 | Senkypl DusanDirector, CEO, 10% Owner | Option exercise | M | — 5,750 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 21 | Wheeler Benjamin RichardChief Financial Officer | Grant or award | A | — 206.2K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 21 | Reed Timothy R.EVP, R&D and Tour | Option exercise | M | — 11.4K sh | Mar 16, 2026 traded Mar 14, 2026 |
| 21 | Walsh Mark T.Director, CEO & Director | Option exercise | M | — 93.8K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 21 | Bothwick Jay EDirector | Option exercise | M | — 625 sh | Mar 16, 2026 traded Mar 14, 2026 |
| 21 | Ponrt JiriChief Operating Officer | Option exercise | M | — 2,157 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 21 | Vincent George H.Executive Vice President | Grant or award | A | — 7,605 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 21 | Foust WarrenInterim Co-CEO and Pres. & COO | Option exercise | M | — 19.6K sh | Mar 16, 2026 traded Mar 14, 2026 |
| 21 | Foust WarrenInterim Co-CEO and Pres. & COO | Option exercise | M | — 19.6K sh | Mar 16, 2026 traded Mar 14, 2026 |
| 21 | Komasinski MichaelDirector, CEO | Grant or award | A | — 141.7K sh | Mar 16, 2026 traded Mar 13, 2026 |
| 21 | Adamson Philip B.Chief Medical Officer | Grant or award · 10b5-1 plan | A | — 41.0K sh | Mar 16, 2026 traded Feb 27, 2026 |
| 21 | Donnelly Brian JChief Commerical Officer | Grant or award | A | — 226.8K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 21 | Thiele Candace LEVP, Chief Administrative Offi | Option exercise | M | $34K 405 sh | Mar 16, 2026 traded Mar 15, 2026 |
| 21 | Lebowitz EthanChief Operating Officer | Option exercise | M | — 18.5K sh | Mar 16, 2026 traded Mar 15, 2026 |
| 21 | Bahrenburg James HChief Technology Officer | Grant or award | A | — 4,962 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 21 | Wise James MichaelSVP & Chief Accounting Officer | Option exercise | M | — 2,701 sh | Mar 16, 2026 traded Mar 15, 2026 |
| 21 | Parrish DeanEVP & Chief Operating Officer | Option exercise | M | — 3,197 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 21 | Thiele Candace LEVP, Chief Administrative Offi | Option exercise | M | $34K 398 sh | Mar 16, 2026 traded Mar 15, 2026 |